Plasma Asprosin Levels Are Associated with Glucose Metabolism, Lipid, and Sex Hormone Profiles in Females with Metabolic-Related Diseases

Table 5

Association of plasma asprosin with T2DM or PCOS in fully adjusted models.

Model adjustment	T2DM		PCOS
	OR, 95% CI		OR, 95% CI
Age	2.092 (1.446–3.028)	<0.001	1.670 (1.104–2.526)	0.015
Age, BMI	2.183 (1.470–3.243)	<0.001	1.774 (1.068–2.949)	0.027
Age, BMI, WBC	2.242 (1.480–3.398)	<0.001	1.979 (1.126–3.476)	0.018
Age, BMI, SBP, DSP	2.288 (1.483–3.527)	<0.001	1.843 (1.095–3.104)	0.021
Age, BMI, WBC, SBP, DSP	2.253 (1.440–3.523)	<0.001	2.156 (1.160–4.005)	0.015
Age, BMI, WBC, SBP, DSP, HDL, TG, LDL, TC	2.149 (1.307–3.531)	0.003	2.483 (1.102–5.596)	0.028
Age, BMI, WBC, SBP, DSP, HDL, TG, LDL, TC, ALT, AST	2.789 (1.362–5.748)	0.005	2.385 (0.980–5.809)	0.056
Age, BMI, WBC, SBP, DSP, HDL, TG, LDL, TC, ALT, AST, γ-GGT	2.790 (1.132–6.874)	0.026	2.321 (0.917–5.874)	0.075

Note: Results of binary logistic regression analyses are presented. OR: odds ratio; CI: confidence interval.